🔗 Permalink

Inventor profile of:

Tuula RYDE

City:

Malvern, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2021-04-22

Top Assignees for applications by Tuula RYDE

The entities that hold a legal rights for patent applications filed by inventor RYDE Tuula:

ALKERMES PHARMA IRELAND LIMITED 5 Dublin, Ireland
ALKERMES PHARMA IRELAND LIMITED 3 Dublin 4, Ireland
Recro Pharma, Inc. 2 Malvern, PA United States
Elan Pharma International Ltd. 2 Athlone County Westmeath, Ireland
Fournier Laboratories Ireland, Ltd. 2 Carrigtwohill, County Cork, Ireland
Fournier Laboratories Ireland Ltd. 1 Cork, Ireland
BAUDAX BIO, INC. 1 Malvern, PA United States
Elan Pharma International Limited 1 Dublin, Ireland
Fournier Laboratories Ireland Ltd. 1 Cork, Israel
Elan Pharma International, Ltd. 1 Athlone, Co. Westmeath, Ireland
Elan Pharma International, Ltd. 1 Athlone, County Westmath, Israel
Elan Pharma International, Ltd. 1 County Clare, Ireland

Recent patent applications by RYDE Tuula

Tuula RYDE from Malvern, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-04-22

US20210113580A1

Human necessities

NANOPARTICULATE MELOXICAM FORMULATIONS

#2 | 2020-05-21

US20200155564A1

Human necessities

Nanoparticulate Meloxicam Formulations

#3 | 2019-12-19

US20190381062A1

Human necessities

Nanoparticulate meloxicam formulations

#4 | 2018-08-16

US20180228810A1

Human necessities

Nanoparticulate Meloxicam Formulations

#5 | 2018-08-16

US20180228809A1

Human necessities

Nanoparticulate meloxicam formulations

#6 | 2017-06-08

US20170157061A1

Human necessities

Nanoparticulate meloxicam formulations

#7 | 2015-11-12

US20150320682A1

Human necessities

NANOPARTICULATE MEGESTROL FORMULATIONS

#8 | 2015-03-26

US20150086635A1

Human necessities

Nanoparticulate megestrol formulations

#9 | 2015-02-26

US20150056287A1

Human necessities

Nanoparticulate megestrol formulations

#10 | 2015-02-26

US20150056286A1

Human necessities

Nanoparticulate megestrol formulations

#11 | 2014-05-22

US20140141083A1

Human necessities

NANOPARTICULATE MELOXICAM FORMULATIONS

#12 | 2013-09-26

US20130251805A1

Human necessities

LOW VISCOSITY LIQUID DOSAGE FORMS

#13 | 2013-08-20

US10784900

Nanoparticulate meloxicam formulations

#14 | 2012-04-12

US20120087955A1

Human necessities

NANOPARTICULATE MEGESTROL FORMULATIONS

#15 | 2011-02-03

US20110027371A1

Human necessities

Nanoparticulate statin formulations and novel statin combinations

#16 | 2010-12-30

US20100329976A1

Human necessities

NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS

#17 | 2010-12-23

US20100322852A1

Human necessities

NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS

#18 | 2010-11-25

US20100297252A1

Human necessities

NANOPARTICULATE MELOXICAM FORMULATIONS

#19 | 2010-10-21

US20100266705A1

Human necessities

NANOPARTICULATE MEGESTROL FORMULATIONS

#20 | 2010-09-09

US20100226989A1

Human necessities

Nanoparticulate megestrol formulations

#21 | 2008-11-13

US20080279949A1

Human necessities

NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS

#22 | 2008-09-18

US20080226732A1

Human necessities

NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS

#23 | 2008-09-11

US20080220075A1

Human necessities

Nanoparticulate compositions of angiogenesis inhibitors

#24 | 2008-09-04

US20080213378A1

Human necessities

Nanoparticulate statin formulations and novel statin combinations

#25 | 2008-07-17

US20080171088A1

Human necessities

Nanoparticulate megestrol formulations

#26 | 2008-06-26

US20080152585A1

Human necessities

Low viscosity liquid dosage forms

#27 | 2008-06-24

US10766960

Nanoparticulate topiramate formulations

#28 | 2008-06-12

US20080138424A1

Human necessities

Nanoparticulate fibrate formulations

#29 | 2008-05-08

US20080107741A1

Human necessities

NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS

#30 | 2008-04-24

US20080095851A1

Human necessities

Nanoparticulate fibrate formulations

#31 | 2008-02-28

US20080050461A1

Human necessities

NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS

#32 | 2008-01-22

US10692855

Methods of treatment using nanoparticulate fenofibrate compositions

#33 | 2007-12-27

US20070298115A1

Human necessities

Nanoparticulate fibrate formulations

#34 | 2007-11-15

US20070264348A1

Human necessities

Nanoparticulate fibrate formulations

#35 | 2006-09-05

US10412669

Nanoparticulate megestrol formulations

#36 | 2005-12-15

US20050276974A1

Human necessities

Nanoparticulate fibrate formulations

#37 | 2005-10-20

US20050233001A1

Human necessities

Nanoparticulate megestrol formulations

#38 | 2005-03-24

US20050063913A1

Human necessities

Novel metaxalone compositions

#39 | 2005-01-13

US20050008707A1

Human necessities

Nanoparticulate megestrol formulations

InventorID:

455337 ⎘